Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 12845329.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This report describes a transfection-independent system for packaging alphavirus replicon vectors using modified vaccinia virus Ankara (MVA) vectors to express all of the RNA components necessary for the production of Venezuelan equine encephalitis (VEE) virus replicon particles (VRP). Infection of mammalian cells with these recombinant MVA vectors resulted in robust expression of VEE structural genes, replication of the alphavirus vector and high titers of VRP. In addition, VRP packaging was achieved in a cell type (fetal rhesus lung) that has been approved for the manufacturing of vaccines destined for human use.
Medical subject headings
- DNA, Viral
- Drug Delivery Systems
- Encephalitis Virus, Venezuelan Equine
- Gene Transfer Techniques
- Genetic Vectors
- Replicon
- Transfection
- Vaccinia virus
- Virion